Rabies immunoglobulin

Kedrab

150IU/ML SolutionUnited StatesMarketedAuthorised 23 Aug 2017

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

HyperrabCanada · 300 UNIT / ML · Solution · Grifols Therapeutics LLCSame strength and form
KamrabCanada · 150 UNIT / ML · Solution · Kamada LTDSame strength and form
KamrabCanada · 150 UNIT / ML · Solution · Kamada LTDSame strength and form
IZ HRIG 500 Imunoglobulin protiv bjesnoće, ljudski, 500 IU/bočici, otopina za injekcijuCroatia · otopina za injekciju · Imunološki zavod d.d., Rockefellerova 2, Zagreb, HrvatskaSame substance
HyperRAB Solution for Infiltration & Intramuscular InjectionSingapore · 300 iu/ml · injection · Grifols Asia Pacific Pte. LTD.Same substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Rabies immunoglobulin

Kedrab

150IU/ML SolutionUnited StatesMarketedAuthorised 23 Aug 2017

Ask Osler about it

In other countries

The same active substances on other registers, the same brand first.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

U.S. Food and Drug Administration

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions · Added 11 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Rabies immunoglobulin
Strength: 150IU/ML
Dosage form: Solution
Route: Subcutaneous
Register: United States (FDA)
Status: Marketed
Status in the register: Licensed / Rx
Authorised: 23 Aug 2017
Registration: BLA 125613
Marketing authorisation holder: Kamada Ltd.
Procedure: 351(a)
Supply: Rx

Bayrab, HyperrabRabies immunoglobulin · 300IU/ML · InjectionUnited States

ImogamRabies immunoglobulin · 150IU/ML · For InjectionUnited StatesWithdrawn